Facebook Pixel Ireland Provides an Easy Market Into Europe | Bio Spectrum - Business - Lee esta historia en Magzter.com
Vuélvete ilimitado con Magzter GOLD

Vuélvete ilimitado con Magzter GOLD

Obtenga acceso ilimitado a más de 9000 revistas, periódicos e historias Premium por solo

$149.99
 
$74.99/Año

Intentar ORO - Gratis

Ireland Provides an Easy Market Into Europe

Bio Spectrum

|

December 2016

Sahajanand Medical Technologies (SMt) is developer and manufacturer of minimal-ly invasive coronary stent systems in India and supplies to around 60 countries in Europe, Asia, MENA and Latin America. the company has received numerous awards for its breakthrough innovations and quality, that have led to thinner and more flexible DES (drug-eluting stents) with good long term clinical results.

SMT is establishing its European headquarters, including Research, Development and Innovation centre in Ireland. We chat with SMt’s Western European Head, Gaurav Goel, to know more about it.

- Ayesha Siddiqui

Ireland Provides an Easy Market Into Europe

Gaurav Goel

Western European Head, Sahajanand Medical Technologies (SMT)

Q: What is the rationale behind setting up an office in Ireland?

A: Ireland is well known as the medical device hub of the world. 15 of the top 20 global medtech companies operate in Ireland. Ireland provides a complete eco-system in terms of infrastructure, highly skilled manpower, raw material and capital goods suppliers at close proximity. When SMT wanted to expand into the European market, it scouted various countries in Europe. The major thrust was to find out a suitable country where we could address our multiple requirements and Ireland was our answer. Ireland fits perfectly into our short term and long term goals. We look forward to bringing together our Indian talent along with the high skilled manpower available in Ireland to become a major global medical device player.

Q: Could you please throw some light on SMt’s product portfolio? What are your areas of focus as far as product services are concerned?

MÁS HISTORIAS DE Bio Spectrum

Bio Spectrum

Bio Spectrum

Can India's CDMOS Lead the Next Biopharma Wave?

India's Contract, Development, and Manufacturing Organisation (CDMO) sector is projected to grow from $3-3.5 billion today to $22-25 billion by 2035, noted Boston Consulting Group (BCG).

time to read

8 mins

March 2026

Bio Spectrum

Bio Spectrum

Telangana turns catalyst for innovation

Telangana is at a pivotal moment in its journey as a global life sciences hub.

time to read

6 mins

March 2026

Bio Spectrum

Bio Spectrum

Is AI the New Weapon in the Fight to End TB?

A report released at the India AI Impact Summit 2026, organised by the Government of India, reveals that artificial intelligence (AI) is being successfully deployed at scale across India’s public healthcare system to address the growing burden of tuberculosis (TB).

time to read

2 mins

March 2026

Bio Spectrum

Bio Spectrum

ChemWerth on-boards Chandrakanth Reddy as new GSM to increase generic API footprint in India

US-based ChemWerth, Inc., a global leader in generic active pharmaceutical ingredient (API) development and supply, continues to expand its footprint and strengthen its position in the Indian market.

time to read

1 min

March 2026

Bio Spectrum

Bio Spectrum

Beyond the Glass Ceiling: Women-Led Companies Shaping India's Health Economy

Over the past decade, women entrepreneurs have gained strong ground in India's healthcare sector, building ventures in diagnostics, FemTech, biotech, and care delivery.

time to read

5 mins

March 2026

Bio Spectrum

Bio Spectrum

"There needs to be a collaborative effort between innovators and policymakers to create frameworks that ensure safety without stifling progress"

Started in 2021, Decode Age, one of the pioneers in Longevity Research in India, entered its next phase of growth following its Pre-Series A funding round, led by Granules India.

time to read

5 mins

March 2026

Bio Spectrum

Bio Spectrum

Rainbow Children's Medicare appoints Abrarali Dalal as Chief Executive Officer

Rainbow Children's Medicare, a leading provider of paediatrics, perinatal, and women's healthcare services in India, has announced the appointment of Abrarali Dalal as Chief Executive Officer, effective from January 20, 2026.

time to read

1 min

March 2026

Bio Spectrum

Bio Spectrum

Haleon ropes in Kedar Lele as President for India Subcontinent

Haleon, a British multinational consumer healthcare company has announced the appointment of Kedar Lele as President for India Subcontinent (ISC), effective January 2026.

time to read

1 min

March 2026

Bio Spectrum

Bio Spectrum

Centre revises Startup Recognition Framework to strengthen Startup India Action Plan

The government of India has revamped the Startup Recognition Framework to further strengthen the Startup India Action Plan and take forward the Prime Minister's vision of positioning India as a global innovation powerhouse, manufacturing-led economy and hub for emerging tech.

time to read

1 min

March 2026

Bio Spectrum

Bio Spectrum

"In the coming 5 years from now, no Indian CROS will grow or survive without the use of AI"

In January 2026, Ahmedabad-based Veeda Lifesciences announced a strategic leadership transition that marks a new chapter in the company's evolution.

time to read

5 mins

March 2026

Translate

Share

-
+

Change font size